← Insider buys
XLRN

Acceleron Pharma Inc

Director Karen L. Smith sold $1.2M of Acceleron Pharma Inc

Sold$1,218,003
$136.47Price
8,925Shares
−66%Stake

What XLRN did after the filing

Prices for XLRN after this filing aren't in yet.

Traded Thu, Apr 1. Filed Fri, Apr 2, 2:00 PM ET, during the session. Not investment advice.